Jove
Visualize
Contact Us

Related Experiment Videos

[Behçet's disease].

T Hashimoto1

  • 1Department of Internal Medicine, Teikyo University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 17, 1999
PubMed
Summary
This summary is machine-generated.

Behçet

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy.

Cancer·1992
Same author

Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition.

Proceedings of the National Academy of Sciences of the United States of America·1992
Same author

Protein kinase C-independent sensitization of contractile proteins to Ca2+ in alpha-toxin-permeabilized smooth muscle cells from the guinea-pig stomach.

British journal of pharmacology·1992
Same author

Recurrent annular erythema associated with anti-SS-B/La antibodies: analysis of the disease-specific epitope.

The British journal of dermatology·1992
Same author

Magnetic resonance imaging of the brain structures in the posterior fossa in retarded autistic children.

Acta paediatrica (Oslo, Norway : 1992)·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Pathology
  • Pharmacology

Context:

  • Behçet's disease involves neutrophil and platelet hyperfunction, leading to tissue damage via active oxygen and lysosomal enzyme release.
  • The role of cytokines from mononuclear cells in neutrophil hyperfunction is increasingly understood.
  • Advances in understanding Behçet's disease pathogenesis have driven the development of new treatments.

Purpose:

  • To review the clinicopathological characteristics of Behçet's disease.
  • To discuss the mechanisms underlying neutrophil hyperfunction in Behçet's disease.
  • To highlight recent therapeutic advancements in managing Behçet's disease.

Summary:

  • Behçet's disease pathogenesis involves neutrophil and platelet hyperfunction, with cytokines from mononuclear cells playing a key role.

Related Experiment Videos

  • Therapeutic progress includes anti-inflammatory drugs, immunosuppressants, anti-thrombotics, and anticoagulants.
  • Cyclosporine shows significant efficacy in severe uveitis, and methotrexate may benefit neuro-Behçet's disease.

    • Impact:

    • Improved understanding of Behçet's disease mechanisms.
    • Development of targeted therapies for Behçet's disease.
    • Enhanced treatment outcomes for patients with Behçet's disease, particularly those with severe manifestations.